Infliximab BS IV infusion 100mg “Nichi-Iko” contains infliximab (genetical recombination) [infliximab follow-up 2]. Manufactured by Nichi-Iko, this TNF-alpha blocker is indicated for inflammatory conditions like rheumatoid arthritis, Crohn’s disease, and ulcerative colitis. It is packaged as 100mg x 1 bottle with YJ code 2399404F1033.
Infliximab BS IV infusion 100mg “Nichi-Iko”
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →